Leydig cell aging: Molecular mechanisms and treatments

Area of Science:

• Endocrinology
• Molecular Biology
• Aging Research

Background:

• Late-onset hypogonadism affects millions of aging men, decreasing quality of life due to low serum testosterone.
• Testosterone synthesis in Leydig cells (LCs) is initiated by luteinizing hormone (LH) binding, triggering the formation of the Steroidogenic InteracTomE (SITE) complex.
• Aging impairs LC function, leading to oxidative stress, altered SITE complexes, and reduced testosterone production.

Purpose of the Study:

• To explore novel strategies for increasing testosterone production in aging men.
• To investigate targeting Leydig cell protein-protein interactions as a therapeutic approach.
• To enhance the function of hypofunctional Leydig cells.

Main Methods:

• Analysis of Leydig cell function and the Steroidogenic InteracTomE (SITE) complex in aging.
• Investigating the role of intracellular oxidative environment in Leydig cell defects.
• Exploring protein-protein interactions within Leydig cells as therapeutic targets.

Main Results:

• Aging is associated with defects in Leydig cells, including alterations in the SITE complex and increased oxidative stress.
• These cellular changes contribute to decreased androgen formation and lower serum testosterone levels.
• Protein-protein interactions within Leydig cells represent a potential target for therapeutic intervention.

Conclusions:

• Targeting Leydig cell protein-protein interactions offers a promising strategy to increase testosterone production.
• This approach could provide an alternative or adjunct to testosterone replacement therapy (TRT).
• Enhancing the function of aging Leydig cells may improve health and quality of life for aging men.